Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1404176.RAqp6R_-8iPf86UZO0DfISjdf_CmER1BTWQaPNXW6e2FU130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1404176.RAqp6R_-8iPf86UZO0DfISjdf_CmER1BTWQaPNXW6e2FU130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1404176.RAqp6R_-8iPf86UZO0DfISjdf_CmER1BTWQaPNXW6e2FU130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1404176.RAqp6R_-8iPf86UZO0DfISjdf_CmER1BTWQaPNXW6e2FU130_provenance.
- befree-2016 importedOn "2016-02-19" NP1404176.RAqp6R_-8iPf86UZO0DfISjdf_CmER1BTWQaPNXW6e2FU130_provenance.
- NP1404176.RAqp6R_-8iPf86UZO0DfISjdf_CmER1BTWQaPNXW6e2FU130_assertion wasGeneratedBy ECO_0000203 NP1404176.RAqp6R_-8iPf86UZO0DfISjdf_CmER1BTWQaPNXW6e2FU130_provenance.
- NP1404176.RAqp6R_-8iPf86UZO0DfISjdf_CmER1BTWQaPNXW6e2FU130_assertion wasDerivedFrom befree-2016 NP1404176.RAqp6R_-8iPf86UZO0DfISjdf_CmER1BTWQaPNXW6e2FU130_provenance.
- NP1404176.RAqp6R_-8iPf86UZO0DfISjdf_CmER1BTWQaPNXW6e2FU130_assertion SIO_000772 9742914 NP1404176.RAqp6R_-8iPf86UZO0DfISjdf_CmER1BTWQaPNXW6e2FU130_provenance.
- NP1404176.RAqp6R_-8iPf86UZO0DfISjdf_CmER1BTWQaPNXW6e2FU130_assertion evidence source_evidence_literature NP1404176.RAqp6R_-8iPf86UZO0DfISjdf_CmER1BTWQaPNXW6e2FU130_provenance.
- NP1404176.RAqp6R_-8iPf86UZO0DfISjdf_CmER1BTWQaPNXW6e2FU130_assertion description "[Thus, immunotherapy with high-dose bolus IL-2 should be considered as initial therapy for appropriately selected patients with metastatic melanoma and renal cell cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1404176.RAqp6R_-8iPf86UZO0DfISjdf_CmER1BTWQaPNXW6e2FU130_provenance.